Antitumor activity of an immunocytokine composed of an anti-GD2 antibody and the IL-15 superagonist RLI.
about
Trial Watch: Adoptive cell transfer for oncological indicationsTrial Watch:: Oncolytic viruses for cancer therapyTrial Watch-Oncolytic viruses and cancer therapyTrial Watch: Peptide-based anticancer vaccines.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.
P2860
Antitumor activity of an immunocytokine composed of an anti-GD2 antibody and the IL-15 superagonist RLI.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antitumor activity of an immun ...... nd the IL-15 superagonist RLI.
@en
Antitumor activity of an immun ...... nd the IL-15 superagonist RLI.
@nl
type
label
Antitumor activity of an immun ...... nd the IL-15 superagonist RLI.
@en
Antitumor activity of an immun ...... nd the IL-15 superagonist RLI.
@nl
prefLabel
Antitumor activity of an immun ...... nd the IL-15 superagonist RLI.
@en
Antitumor activity of an immun ...... nd the IL-15 superagonist RLI.
@nl
P2860
P356
P1433
P1476
Antitumor activity of an immun ...... nd the IL-15 superagonist RLI.
@en
P2093
Marie Vincent
Yannick Jacques
P2860
P304
P356
10.4161/ONCI.26441
P577
2013-10-09T00:00:00Z